School of Medicine
Showing 21-40 of 42 Results
-
Juan Rivas-Davila
Associate Professor of Electrical Engineering and Senior Fellow at the Precourt Institute for Energy
Current Research and Scholarly InterestsModern applications demand power capabilities beyond what is presently achievable. High performance systems need high power density and bandwidth that are difficult to achieve.
Power density can be improved with better semiconductors and passive componets, and by reducing the energy storage requirements of the system. By dramatically increasing switching frequency it is possible to reduce size of power converters. I'm interested in high performance/frequency circuits switching >10 MHz. -
Thomas Robinson
The Irving Schulman, M.D. Professor of Child Health, Professor of Medicine (Stanford Prevention Research Center) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Robinson originated the solution-oriented research paradigm and directs the Stanford Solutions Science Lab. He is known for his pioneering obesity prevention and treatment research, including the concept of stealth interventions. His research applies social cognitive models of behavior change to behavioral, social, environmental and policy interventions for children and families in real world settings, making the results relevant for informing clinical and public health practice and policy.
-
Stanley G. Rockson, MD
Allan and Tina Neill Professor of Lymphatic Research and Medicine
Current Research and Scholarly InterestsMy clinical research includes studies on risk factor modification in atherosclerosis and coronary artery disease; clinical trials involving medical therapies for peripheral arterial insufficiency; coronary angiogenesis; therapy of lymphedema; atherand photodynamic therapy in atherosclerosis.
-
Fatima Rodriguez
Associate Professor of Medicine (Cardiovascular Medicine)
BioFatima Rodriguez, MD, MPH is an Associate Professor in the Division of Cardiovascular Medicine and Section Chief of Preventive Cardiology at Stanford University. She received her medical degree from Harvard Medical School and a Master of Public Health from the Harvard T.H. Chan School of Public Health. Dr. Rodriguez completed her internal medicine residency at Brigham and Women’s Hospital and fellowship in cardiovascular medicine at Stanford.
Dr. Rodriguez specializes in the prevention and management of cardiovascular disease, with clinical expertise in coronary artery disease and inherited lipid disorders. Her research focuses on advancing cardiovascular health equity, leveraging digital tools to improve guideline-based care, and using AI-enabled approaches for early detection of atherosclerosis. -
Albert "A.J." Rogers, MD, MBA, FAHA
Instructor, Medicine - Cardiovascular Medicine
BioDr. Rogers is a board-certified, fellowship-trained cardiologist with the Cardiac Arrhythmia Service at Stanford Health Care. He is also an instructor of medicine in the Division of Cardiovascular Medicine, Department of Medicine at Stanford University School of Medicine.
As a clinical cardiac electrophysiologist, Dr. Rogers’ training includes evaluating issues involving electrical activity in the heart and how these can lead to an abnormal heart rhythm (arrhythmia). His expertise includes mapping regions in the heart associated with arrhythmias and then applying a minimally invasive therapy (ablation) that targets the responsible areas causing the problem. He also performs procedures to implant cardiac devices, such as pacemakers and defibrillators, designed to synchronize heart contractions and reset irregular heartbeats.
Dr. Rogers specializes in the diagnosis and treatment of atrial fibrillation, ventricular tachycardia, and other arrhythmias. In collaboration with Stanford Medicine cardiovascular surgeons, he performs hybrid surgical-catheter ablation procedures as a more permanent treatment for persistent forms of atrial fibrillation and for inappropriate sinus tachycardia. During this procedure, ablation therapy is applied to areas both inside and outside of the heart responsible for the arrhythmia.
As a physician-researcher, Dr. Rogers’ translational research applies biomedical engineering and machine learning approaches to explore the mechanisms underlying cardiac arrhythmia. These efforts include research funded by the National Institutes of Health and the American Heart Association to investigate novel methods for diagnosing and treating heart rhythm disorders. Dr. Rogers has over 10 years of experience with medical technology innovation and development.
Dr. Rogers serves as associate editor of the Journal of Invasive Cardiovascular Electrophysiology. He is also a peer reviewer for multiple prestigious journals, including Heart Rhythm, The Lancet: Digital Health, the Journal of the American College of Cardiology: Clinical Electrophysiology, and Frontiers in Physiology. He has been an invited guest speaker at national and international meetings, including those for the American Heart Association and the European Cardiac Arrythmia Society. -
Angela Rogers
Associate Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Morteza Roodgar DVM, PhD
Veterinarian Research Scientist, Genetics
BioDr. Morteza Roodgar is a veterinarian scientist with a research focus on Primate induced Pluripotent Stem Cells (iPSCs) and long-read genomics tools.
Dr. Roodgar's research focus is on primate stem cell biology, immunology, and comparative genomics of nonhuman primate models for human diseases. The long-term goal of Dr. Roodgar's research is to Replace, Reduce and Refine (aka 3 R’s) the use of animals in biomedical research leveraging primate induced pluripotent stem cells (iPSCs) and long-read genomic tools to speed up preclinical testing.
Previous research includes immunology and genomic susceptibility to infectious diseases (e.g., tuberculosis, TB) in nonhuman primate models, Preventive Veterinary Medicine and emerging zoonotic diseases (e.g., COVID-19 and Monkeypox). -
Michal Bental Roof
Academic Prog Prof 3, Pediatrics - Cardiology
Current Role at StanfordI joined the Cardiopulmonary Research Program of Drs. Rabinovitch and Bland at Stanford University in 2002, as the Academic and Research Program Officer, and since 2020 assumed my role at the Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, directed by Dr. Rabinovitch. I organize the educational activities of the lab, and assist the faculty and fellows with the preparation of grant proposals, IRB, APLAC and Biosafety protocols, manuscripts, and presentations. I served as the Site Coordinator for the Stanford Transplant Procurement Center of the Pulmonary Hypertension Breakthrough Initiative (PHBI), headed by Dr. Rabinovitch,that now evolved into the Stanford Transplant Tissue Bank. In this capacity, I oversee patient recruitment, data collection and reporting, and ensure compliance with university and federal guidelines. I coordinated and prepared the application for an Investigational New Drug (IND) and the pre-IND meeting that preceded that, for Elafin as a therapy for pulmonary arterial hypertension (PAH) to the FDA in August 2017, and with the Study PIs coordinated the Phase 1 clinical trial “Safety and Tolerability of Escalating Doses of Subcutaneous Elafin (Tiprelestat) Injection in Healthy Normal Subjects” that followed.
From 2005-2015, I served as the Administrative Coordinator of the Cardiovascular and Pulmonary Science Scholarly Concentration for medical students at Stanford University School of Medicine. This includes facilitating communication of the four co-Directors with the School of Medicine Administration, the medical students, and the faculty mentors. An important component of this role is the coordination of the MED223 course, a medical school course where faculty and fellows present new developments in cardiovascular science in the form of a journal club. From 2013-2018, I was the coordinator for the NIH-NHLBI T32 “Mechanisms and Innovation in Vascular Disease” (PI: RL Dalman), and from 2013 to date for NIH-NHLBI K12 HL120001 “Stanford Career Development Program in ‘Omics’ of Lung Disease”. (PIs: M Rabinovitch, MR Nicolls and MP Snyder). This included recruitment of candidates, oversight of training activities, ensuring compliance with NIH and Stanford policies, and acting as a liaison between the trainees and the Directors to facilitate effective communication.
Prior to joining Stanford, I was Associate Director (Scientific Development Administrator) at the Institute for Medicine and Engineering, directed by Dr. Peter Davies at the University of Pennsylvania. In this role, I was the liaison with federal funding agencies and organized multi-investigator program projects and training grants. -
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
David Rosenthal
Professor of Pediatrics (Pediatric Cardiology)
Current Research and Scholarly InterestsResearch interests include the study of Heart Failure, Cardiomyopathy and ventricular dysfunction in children, from a clinical perspective. Investigations include clinical trials of medications, cardiac resynchronization, and mechanical circulatory support.
-
Stephen J. Roth
Professor of Pediatrics (Cardiology)
On Partial Leave from 03/13/2025 To 05/22/2025Current Research and Scholarly InterestsRandomized Therapeutic Trials in Pediatric Heart Disease, NIH/U01 GrantNo. HL68285 2001-2006.
Heparin and the Reduction of Thrombosis (HART) Study. Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006.
A Pilot Trial fo B-type Natriuretic Peptide for Promotion of Urine Output in Diuretic-Resistant Infants Following Cardiovascular Surgery.Pediatric Health Research Fund Award, Stanford Univ Sch of Medicine, 2005-2006. -
Chawannuch Ruaengsri
Clinical Assistant Professor, Cardiothoracic Surgery
Current Research and Scholarly Interests- Cardiac Transplant
- Mechanical Circulatory Support
- Atrial Fibrillation Surgery
- Minimally Invasive Cardiac Surgery
